HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N R Salvetti Selected Research

Follicular Cyst (Follicular Cysts)

7/2022A review on inflammation and angiogenesis as key mechanisms involved in the pathogenesis of bovine cystic ovarian disease.
10/2019Contribution of the VEGF system to the follicular persistence associated with bovine cystic ovaries.
10/2018Alterations in key metabolic sensors involved in bovine cystic ovarian disease.
4/2018Altered expression of IL-1β, IL-1RI, IL-1RII, IL-1RA and IL-4 could contribute to anovulation and follicular persistence in cattle.
7/2017Altered expression of cytokines IL-1α, IL-6, IL-8 and TNF-α in bovine follicular persistence.
2/2017Involvement of Matrix Metalloproteinases and their Inhibitors in Bovine Cystic Ovarian Disease.
8/2015Altered Expression of Pro-inflammatory Cytokines in Ovarian Follicles of Cows with Cystic Ovarian Disease.
5/2015Impaired insulin signaling pathway in ovarian follicles of cows with cystic ovarian disease.
10/2014Altered expression of transforming growth factor-beta isoforms in bovine cystic ovarian disease.
10/2013Ovarian localization of 11β-hydroxysteroid dehydrogenase (11βHSD): effects of ACTH stimulation and its relationship with bovine cystic ovarian disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


N R Salvetti Research Topics

Disease

13Ovarian Diseases (Ovarian Disease)
10/2018 - 04/2007
12Follicular Cyst (Follicular Cysts)
07/2022 - 01/2007
4Cysts
02/2017 - 04/2007
1Anovulation
04/2018
1Rupture
02/2017
1Necrosis
08/2015
1Infertility (Sterility)
10/2013
1Ovarian Cysts (Ovarian Cyst)
10/2009
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2007

Drug/Important Bio-Agent (IBA)

4CytokinesIBA
07/2022 - 08/2015
4Proteins (Proteins, Gene)FDA Link
10/2018 - 05/2015
3Messenger RNA (mRNA)IBA
02/2017 - 05/2015
3Adrenocorticotropic Hormone (ACTH)FDA Link
10/2014 - 01/2007
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2019 - 04/2007
2AntralIBA
10/2018 - 10/2013
2Insulin (Novolin)FDA Link
10/2018 - 05/2015
2Protein Isoforms (Isoforms)IBA
10/2014 - 10/2009
2Estrogens (Estrogen)FDA Link
10/2009 - 05/2007
2Progesterone Receptors (Progesterone Receptor)IBA
10/2009 - 05/2007
1Adiponectin ReceptorsIBA
10/2018
1Adenosine Monophosphate (AMP)IBA
10/2018
1Carnitine (L-Carnitine)FDA LinkGeneric
10/2018
1Protein Kinases (Protein Kinase)IBA
10/2018
1TransferasesIBA
10/2018
1LeptinIBA
10/2018
1Acyl-CoA OxidaseIBA
10/2018
1AdiponectinIBA
10/2018
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
04/2018
1Interleukin-4 (Interleukin 4)IBA
04/2018
1Complement System Proteins (Complement)IBA
04/2018
1Tissue Inhibitor of Metalloproteinase-2IBA
02/2017
1Matrix Metalloproteinases (MMPs)IBA
02/2017
1Metalloproteases (Metalloproteinases)IBA
02/2017
1GelatinasesIBA
02/2017
1Tissue Inhibitor of Metalloproteinase-1IBA
02/2017
1Peptide Hydrolases (Proteases)FDA Link
08/2015
1InterleukinsIBA
08/2015
1Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA
08/2015
1Interleukin-6 (Interleukin 6)IBA
08/2015
1Transforming Growth Factor beta (TGF-beta)IBA
10/2014
1GlucocorticoidsIBA
10/2013
1EnzymesIBA
10/2013
1Oxidoreductases (Dehydrogenase)IBA
10/2013
1Hydrocortisone (Cortisol)FDA LinkGeneric
10/2013
1Insulin-Like Growth Factor II (Somatomedin A)IBA
02/2010
1Insulin-Like Growth Factor Binding ProteinsIBA
02/2010
1Steroid Receptors (Steroid Receptor)IBA
10/2009
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
10/2009
1Naloxone (Narcan)FDA LinkGeneric
04/2008
1DesminIBA
05/2007
1Cytoskeletal ProteinsIBA
05/2007
1Estrogen Receptor alphaIBA
05/2007
1VimentinIBA
05/2007
1Insulin-Like Growth Factor I (IGF-1)IBA
04/2007